Its from June, but I find it hard to believe that things have changed much.
What: Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharma focused on diseases of the central nervous system, were up more than 12% as of 3:30 p.m. ET on rumors that AstraZeneca PLC (ADR) (NYSE:AZN) is eyeing the company as a potential acquisition candidate.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.